Literature DB >> 18629430

Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation.

Katharina Domschke1, Stephan Stevens, Beate Beck, Anna Baffa, Christa Hohoff, Jürgen Deckert, Alexander L Gerlach.   

Abstract

Blushing is considered to be one of the prime pathophysiological markers of social anxiety disorder, potentially mediated by serotonergic function. Therefore, in the present study 62 patients with social anxiety disorder and 62 age- and sex-matched healthy controls were investigated for the influence of serotonin transporter (5-HTT) gene variation (5-HTTLPR, rs25531) on blushing propensity as measured by the blushing propensity scale (BPS). The less active 5-HTTLPR genotypes were nominally significantly associated with increased blushing propensity in patients with social anxiety disorder as compared to controls with an equidirectional trend for the less active 5-HTTLPR/rs25531 haplotypes. Even when statistically controlled for influence of depression, this association remained significant. In summary, the present pilot study suggests a potential role of functional serotonin transporter gene variation in blushing propensity warranting replication and encouraging genetic analyses of further intermediate phenotypes of social anxiety disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629430     DOI: 10.1007/s00702-008-0090-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Meta-analysis of serotonin transporter polymorphisms and affective disorders.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Psychiatr Genet       Date:  2004-09       Impact factor: 2.458

2.  Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.

Authors:  J R Wendland; B J Martin; M R Kruse; K-P Lesch; D L Murphy
Journal:  Mol Psychiatry       Date:  2006-03       Impact factor: 15.992

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs.

Authors:  Y Osher; D Hamer; J Benjamin
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

5.  Multidimensional effects of sertraline in social anxiety disorder.

Authors:  Kathryn M Connor; Jonathan R T Davidson; Henry Chung; Ruoyong Yang; Cathryn M Clary
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

6.  Autonomic correlates of social anxiety and embarrassment in shy and non-shy individuals.

Authors:  Stefan G Hofmann; David A Moscovitch; Hyo-Jin Kim
Journal:  Int J Psychophysiol       Date:  2005-11-08       Impact factor: 2.997

7.  The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia.

Authors:  K S Kendler; M C Neale; R C Kessler; A C Heath; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1992-04

Review 8.  Social phobia: everyone's disorder?

Authors:  J W Jefferson
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

9.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia.

Authors:  Tomas Furmark; Maria Tillfors; Håkan Garpenstrand; Ina Marteinsdottir; Bengt Långström; Lars Oreland; Mats Fredrikson
Journal:  Neurosci Lett       Date:  2004-05-27       Impact factor: 3.046

View more
  6 in total

Review 1.  Familial risk factors in social anxiety disorder: calling for a family-oriented approach for targeted prevention and early intervention.

Authors:  Susanne Knappe; Katja Beesdo-Baum; Hans-Ulrich Wittchen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-10-06       Impact factor: 4.785

2.  Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety.

Authors:  Christiane Ziegler; Udo Dannlowski; David Bräuer; Stephan Stevens; Inga Laeger; Hannah Wittmann; Harald Kugel; Christian Dobel; René Hurlemann; Andreas Reif; Klaus-Peter Lesch; Walter Heindel; Clemens Kirschbaum; Volker Arolt; Alexander L Gerlach; Jürgen Hoyer; Jürgen Deckert; Peter Zwanzger; Katharina Domschke
Journal:  Neuropsychopharmacology       Date:  2015-01-07       Impact factor: 7.853

3.  High social support buffers the effects of 5-HTTLPR genotypes within social anxiety disorder.

Authors:  Eva Reinelt; Maren Aldinger; Malte Stopsack; Christian Schwahn; Ulrich John; Sebastian E Baumeister; Hans Jörgen Grabe; Sven Barnow
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-01-10       Impact factor: 5.270

4.  Evaluating the efficacy of endoscopic thoracic sympathectomy for generalized social anxiety disorder with blushing complaints: a comparison with sertraline and no treatment-santiago de chile 2003-2009.

Authors:  Enrique Jadresic; Claudio Súarez; Estela Palacios; Fernanda Palacios; Patricia Matus
Journal:  Innov Clin Neurosci       Date:  2011-11

Review 5.  Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.

Authors:  Avshalom Caspi; Ahmad R Hariri; Andrew Holmes; Rudolf Uher; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2010-03-15       Impact factor: 18.112

6.  5-HTTLPR modulates the recognition accuracy and exploration of emotional facial expressions.

Authors:  Sabrina Boll; Matthias Gamer
Journal:  Front Behav Neurosci       Date:  2014-07-23       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.